<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVJR" lang="spa" raw_text_char_length="1322" raw_text_md5="8d24101360d03f73044c68afe3a6a016" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="55" id="segment-0" start_char="1">
<ORIGINAL_TEXT>Lopinavir/ritonavir no reduce la mortalidad en COVID-19</ORIGINAL_TEXT>
<TOKEN end_char="19" id="token-0-0" morph="none" pos="unknown" start_char="1">Lopinavir/ritonavir</TOKEN>
<TOKEN end_char="22" id="token-0-1" morph="none" pos="word" start_char="21">no</TOKEN>
<TOKEN end_char="29" id="token-0-2" morph="none" pos="word" start_char="24">reduce</TOKEN>
<TOKEN end_char="32" id="token-0-3" morph="none" pos="word" start_char="31">la</TOKEN>
<TOKEN end_char="43" id="token-0-4" morph="none" pos="word" start_char="34">mortalidad</TOKEN>
<TOKEN end_char="46" id="token-0-5" morph="none" pos="word" start_char="45">en</TOKEN>
<TOKEN end_char="55" id="token-0-6" morph="none" pos="unknown" start_char="48">COVID-19</TOKEN>
<TRANSLATED_TEXT>Lopinavir / ritonavir does not reduce mortality in COVID-19</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="230" id="segment-1" start_char="59">
<ORIGINAL_TEXT>El Servicio de Medicina Interna del Hospital 12 de Octubre ha publicado, en colaboración con los servicios de interna de otros centros hospitalarios españoles, una carta en</ORIGINAL_TEXT>
<TOKEN end_char="60" id="token-1-0" morph="none" pos="word" start_char="59">El</TOKEN>
<TOKEN end_char="69" id="token-1-1" morph="none" pos="word" start_char="62">Servicio</TOKEN>
<TOKEN end_char="72" id="token-1-2" morph="none" pos="word" start_char="71">de</TOKEN>
<TOKEN end_char="81" id="token-1-3" morph="none" pos="word" start_char="74">Medicina</TOKEN>
<TOKEN end_char="89" id="token-1-4" morph="none" pos="word" start_char="83">Interna</TOKEN>
<TOKEN end_char="93" id="token-1-5" morph="none" pos="word" start_char="91">del</TOKEN>
<TOKEN end_char="102" id="token-1-6" morph="none" pos="word" start_char="95">Hospital</TOKEN>
<TOKEN end_char="105" id="token-1-7" morph="none" pos="word" start_char="104">12</TOKEN>
<TOKEN end_char="108" id="token-1-8" morph="none" pos="word" start_char="107">de</TOKEN>
<TOKEN end_char="116" id="token-1-9" morph="none" pos="word" start_char="110">Octubre</TOKEN>
<TOKEN end_char="119" id="token-1-10" morph="none" pos="word" start_char="118">ha</TOKEN>
<TOKEN end_char="129" id="token-1-11" morph="none" pos="word" start_char="121">publicado</TOKEN>
<TOKEN end_char="130" id="token-1-12" morph="none" pos="punct" start_char="130">,</TOKEN>
<TOKEN end_char="133" id="token-1-13" morph="none" pos="word" start_char="132">en</TOKEN>
<TOKEN end_char="146" id="token-1-14" morph="none" pos="word" start_char="135">colaboración</TOKEN>
<TOKEN end_char="150" id="token-1-15" morph="none" pos="word" start_char="148">con</TOKEN>
<TOKEN end_char="154" id="token-1-16" morph="none" pos="word" start_char="152">los</TOKEN>
<TOKEN end_char="164" id="token-1-17" morph="none" pos="word" start_char="156">servicios</TOKEN>
<TOKEN end_char="167" id="token-1-18" morph="none" pos="word" start_char="166">de</TOKEN>
<TOKEN end_char="175" id="token-1-19" morph="none" pos="word" start_char="169">interna</TOKEN>
<TOKEN end_char="178" id="token-1-20" morph="none" pos="word" start_char="177">de</TOKEN>
<TOKEN end_char="184" id="token-1-21" morph="none" pos="word" start_char="180">otros</TOKEN>
<TOKEN end_char="192" id="token-1-22" morph="none" pos="word" start_char="186">centros</TOKEN>
<TOKEN end_char="206" id="token-1-23" morph="none" pos="word" start_char="194">hospitalarios</TOKEN>
<TOKEN end_char="216" id="token-1-24" morph="none" pos="word" start_char="208">españoles</TOKEN>
<TOKEN end_char="217" id="token-1-25" morph="none" pos="punct" start_char="217">,</TOKEN>
<TOKEN end_char="221" id="token-1-26" morph="none" pos="word" start_char="219">una</TOKEN>
<TOKEN end_char="227" id="token-1-27" morph="none" pos="word" start_char="223">carta</TOKEN>
<TOKEN end_char="230" id="token-1-28" morph="none" pos="word" start_char="229">en</TOKEN>
<TRANSLATED_TEXT>The Internal Medicine Service of the Hospital 12 de Octubre has published, in collaboration with the internal services of other Spanish hospital centers, a letter in</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="256" id="segment-2" start_char="233">
<ORIGINAL_TEXT>The Journal of Infection</ORIGINAL_TEXT>
<TOKEN end_char="235" id="token-2-0" morph="none" pos="word" start_char="233">The</TOKEN>
<TOKEN end_char="243" id="token-2-1" morph="none" pos="word" start_char="237">Journal</TOKEN>
<TOKEN end_char="246" id="token-2-2" morph="none" pos="word" start_char="245">of</TOKEN>
<TOKEN end_char="256" id="token-2-3" morph="none" pos="word" start_char="248">Infection</TOKEN>
</SEG>
<SEG end_char="275" id="segment-3" start_char="259">
<ORIGINAL_TEXT>acerca del uso de</ORIGINAL_TEXT>
<TOKEN end_char="264" id="token-3-0" morph="none" pos="word" start_char="259">acerca</TOKEN>
<TOKEN end_char="268" id="token-3-1" morph="none" pos="word" start_char="266">del</TOKEN>
<TOKEN end_char="272" id="token-3-2" morph="none" pos="word" start_char="270">uso</TOKEN>
<TOKEN end_char="275" id="token-3-3" morph="none" pos="word" start_char="274">de</TOKEN>
<TRANSLATED_TEXT>about the use of</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="357" id="segment-4" start_char="279">
<ORIGINAL_TEXT>lopinavir/ritonavir y sus posibles beneficios en el tratamiento de la COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="297" id="token-4-0" morph="none" pos="unknown" start_char="279">lopinavir/ritonavir</TOKEN>
<TOKEN end_char="299" id="token-4-1" morph="none" pos="word" start_char="299">y</TOKEN>
<TOKEN end_char="303" id="token-4-2" morph="none" pos="word" start_char="301">sus</TOKEN>
<TOKEN end_char="312" id="token-4-3" morph="none" pos="word" start_char="305">posibles</TOKEN>
<TOKEN end_char="323" id="token-4-4" morph="none" pos="word" start_char="314">beneficios</TOKEN>
<TOKEN end_char="326" id="token-4-5" morph="none" pos="word" start_char="325">en</TOKEN>
<TOKEN end_char="329" id="token-4-6" morph="none" pos="word" start_char="328">el</TOKEN>
<TOKEN end_char="341" id="token-4-7" morph="none" pos="word" start_char="331">tratamiento</TOKEN>
<TOKEN end_char="344" id="token-4-8" morph="none" pos="word" start_char="343">de</TOKEN>
<TOKEN end_char="347" id="token-4-9" morph="none" pos="word" start_char="346">la</TOKEN>
<TOKEN end_char="356" id="token-4-10" morph="none" pos="unknown" start_char="349">COVID-19</TOKEN>
<TOKEN end_char="357" id="token-4-11" morph="none" pos="punct" start_char="357">.</TOKEN>
<TRANSLATED_TEXT>lopinavir / ritonavir and its potential benefits in the treatment of COVID-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="538" id="segment-5" start_char="360">
<ORIGINAL_TEXT>El lopinavir/ritonavir se utilizó en los primeros momentos de la pandemia por su eficacia en el tratamiento del VIH, pero sin que hubiera una evidencia consistente de su eficacia.</ORIGINAL_TEXT>
<TOKEN end_char="361" id="token-5-0" morph="none" pos="word" start_char="360">El</TOKEN>
<TOKEN end_char="381" id="token-5-1" morph="none" pos="unknown" start_char="363">lopinavir/ritonavir</TOKEN>
<TOKEN end_char="384" id="token-5-2" morph="none" pos="word" start_char="383">se</TOKEN>
<TOKEN end_char="392" id="token-5-3" morph="none" pos="word" start_char="386">utilizó</TOKEN>
<TOKEN end_char="395" id="token-5-4" morph="none" pos="word" start_char="394">en</TOKEN>
<TOKEN end_char="399" id="token-5-5" morph="none" pos="word" start_char="397">los</TOKEN>
<TOKEN end_char="408" id="token-5-6" morph="none" pos="word" start_char="401">primeros</TOKEN>
<TOKEN end_char="417" id="token-5-7" morph="none" pos="word" start_char="410">momentos</TOKEN>
<TOKEN end_char="420" id="token-5-8" morph="none" pos="word" start_char="419">de</TOKEN>
<TOKEN end_char="423" id="token-5-9" morph="none" pos="word" start_char="422">la</TOKEN>
<TOKEN end_char="432" id="token-5-10" morph="none" pos="word" start_char="425">pandemia</TOKEN>
<TOKEN end_char="436" id="token-5-11" morph="none" pos="word" start_char="434">por</TOKEN>
<TOKEN end_char="439" id="token-5-12" morph="none" pos="word" start_char="438">su</TOKEN>
<TOKEN end_char="448" id="token-5-13" morph="none" pos="word" start_char="441">eficacia</TOKEN>
<TOKEN end_char="451" id="token-5-14" morph="none" pos="word" start_char="450">en</TOKEN>
<TOKEN end_char="454" id="token-5-15" morph="none" pos="word" start_char="453">el</TOKEN>
<TOKEN end_char="466" id="token-5-16" morph="none" pos="word" start_char="456">tratamiento</TOKEN>
<TOKEN end_char="470" id="token-5-17" morph="none" pos="word" start_char="468">del</TOKEN>
<TOKEN end_char="474" id="token-5-18" morph="none" pos="word" start_char="472">VIH</TOKEN>
<TOKEN end_char="475" id="token-5-19" morph="none" pos="punct" start_char="475">,</TOKEN>
<TOKEN end_char="480" id="token-5-20" morph="none" pos="word" start_char="477">pero</TOKEN>
<TOKEN end_char="484" id="token-5-21" morph="none" pos="word" start_char="482">sin</TOKEN>
<TOKEN end_char="488" id="token-5-22" morph="none" pos="word" start_char="486">que</TOKEN>
<TOKEN end_char="496" id="token-5-23" morph="none" pos="word" start_char="490">hubiera</TOKEN>
<TOKEN end_char="500" id="token-5-24" morph="none" pos="word" start_char="498">una</TOKEN>
<TOKEN end_char="510" id="token-5-25" morph="none" pos="word" start_char="502">evidencia</TOKEN>
<TOKEN end_char="522" id="token-5-26" morph="none" pos="word" start_char="512">consistente</TOKEN>
<TOKEN end_char="525" id="token-5-27" morph="none" pos="word" start_char="524">de</TOKEN>
<TOKEN end_char="528" id="token-5-28" morph="none" pos="word" start_char="527">su</TOKEN>
<TOKEN end_char="537" id="token-5-29" morph="none" pos="word" start_char="530">eficacia</TOKEN>
<TOKEN end_char="538" id="token-5-30" morph="none" pos="punct" start_char="538">.</TOKEN>
<TRANSLATED_TEXT>lopinavir / ritonavir was used in the early stages of the pandemic because of its efficacy in the treatment of HIV, but without consistent evidence of efficacy.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="800" id="segment-6" start_char="540">
<ORIGINAL_TEXT>Ensayos clínicos no han demostrado rotundamente ni los beneficios ni los riesgos, por lo que los investigadores de esta carta han realizado una investigación a partir de una amplia cohorte multicéntrica (Registro SEMI-COVID-19) que superaba los 8 mil pacientes.</ORIGINAL_TEXT>
<TOKEN end_char="546" id="token-6-0" morph="none" pos="word" start_char="540">Ensayos</TOKEN>
<TOKEN end_char="555" id="token-6-1" morph="none" pos="word" start_char="548">clínicos</TOKEN>
<TOKEN end_char="558" id="token-6-2" morph="none" pos="word" start_char="557">no</TOKEN>
<TOKEN end_char="562" id="token-6-3" morph="none" pos="word" start_char="560">han</TOKEN>
<TOKEN end_char="573" id="token-6-4" morph="none" pos="word" start_char="564">demostrado</TOKEN>
<TOKEN end_char="586" id="token-6-5" morph="none" pos="word" start_char="575">rotundamente</TOKEN>
<TOKEN end_char="589" id="token-6-6" morph="none" pos="word" start_char="588">ni</TOKEN>
<TOKEN end_char="593" id="token-6-7" morph="none" pos="word" start_char="591">los</TOKEN>
<TOKEN end_char="604" id="token-6-8" morph="none" pos="word" start_char="595">beneficios</TOKEN>
<TOKEN end_char="607" id="token-6-9" morph="none" pos="word" start_char="606">ni</TOKEN>
<TOKEN end_char="611" id="token-6-10" morph="none" pos="word" start_char="609">los</TOKEN>
<TOKEN end_char="619" id="token-6-11" morph="none" pos="word" start_char="613">riesgos</TOKEN>
<TOKEN end_char="620" id="token-6-12" morph="none" pos="punct" start_char="620">,</TOKEN>
<TOKEN end_char="624" id="token-6-13" morph="none" pos="word" start_char="622">por</TOKEN>
<TOKEN end_char="627" id="token-6-14" morph="none" pos="word" start_char="626">lo</TOKEN>
<TOKEN end_char="631" id="token-6-15" morph="none" pos="word" start_char="629">que</TOKEN>
<TOKEN end_char="635" id="token-6-16" morph="none" pos="word" start_char="633">los</TOKEN>
<TOKEN end_char="650" id="token-6-17" morph="none" pos="word" start_char="637">investigadores</TOKEN>
<TOKEN end_char="653" id="token-6-18" morph="none" pos="word" start_char="652">de</TOKEN>
<TOKEN end_char="658" id="token-6-19" morph="none" pos="word" start_char="655">esta</TOKEN>
<TOKEN end_char="664" id="token-6-20" morph="none" pos="word" start_char="660">carta</TOKEN>
<TOKEN end_char="668" id="token-6-21" morph="none" pos="word" start_char="666">han</TOKEN>
<TOKEN end_char="678" id="token-6-22" morph="none" pos="word" start_char="670">realizado</TOKEN>
<TOKEN end_char="682" id="token-6-23" morph="none" pos="word" start_char="680">una</TOKEN>
<TOKEN end_char="696" id="token-6-24" morph="none" pos="word" start_char="684">investigación</TOKEN>
<TOKEN end_char="698" id="token-6-25" morph="none" pos="word" start_char="698">a</TOKEN>
<TOKEN end_char="705" id="token-6-26" morph="none" pos="word" start_char="700">partir</TOKEN>
<TOKEN end_char="708" id="token-6-27" morph="none" pos="word" start_char="707">de</TOKEN>
<TOKEN end_char="712" id="token-6-28" morph="none" pos="word" start_char="710">una</TOKEN>
<TOKEN end_char="719" id="token-6-29" morph="none" pos="word" start_char="714">amplia</TOKEN>
<TOKEN end_char="727" id="token-6-30" morph="none" pos="word" start_char="721">cohorte</TOKEN>
<TOKEN end_char="741" id="token-6-31" morph="none" pos="word" start_char="729">multicéntrica</TOKEN>
<TOKEN end_char="743" id="token-6-32" morph="none" pos="punct" start_char="743">(</TOKEN>
<TOKEN end_char="751" id="token-6-33" morph="none" pos="word" start_char="744">Registro</TOKEN>
<TOKEN end_char="765" id="token-6-34" morph="none" pos="unknown" start_char="753">SEMI-COVID-19</TOKEN>
<TOKEN end_char="766" id="token-6-35" morph="none" pos="punct" start_char="766">)</TOKEN>
<TOKEN end_char="770" id="token-6-36" morph="none" pos="word" start_char="768">que</TOKEN>
<TOKEN end_char="779" id="token-6-37" morph="none" pos="word" start_char="772">superaba</TOKEN>
<TOKEN end_char="783" id="token-6-38" morph="none" pos="word" start_char="781">los</TOKEN>
<TOKEN end_char="785" id="token-6-39" morph="none" pos="word" start_char="785">8</TOKEN>
<TOKEN end_char="789" id="token-6-40" morph="none" pos="word" start_char="787">mil</TOKEN>
<TOKEN end_char="799" id="token-6-41" morph="none" pos="word" start_char="791">pacientes</TOKEN>
<TOKEN end_char="800" id="token-6-42" morph="none" pos="punct" start_char="800">.</TOKEN>
<TRANSLATED_TEXT>Clinical trials have failed to demonstrate the benefits or risks, so researchers in this letter have conducted research from a large multicentre cohort (SEMI-COVID-19 Registry) that exceeded 8,000 patients.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="896" id="segment-7" start_char="802">
<ORIGINAL_TEXT>Se trata del estudio con el mayor número de pacientes que analiza este tratamiento en COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="803" id="token-7-0" morph="none" pos="word" start_char="802">Se</TOKEN>
<TOKEN end_char="809" id="token-7-1" morph="none" pos="word" start_char="805">trata</TOKEN>
<TOKEN end_char="813" id="token-7-2" morph="none" pos="word" start_char="811">del</TOKEN>
<TOKEN end_char="821" id="token-7-3" morph="none" pos="word" start_char="815">estudio</TOKEN>
<TOKEN end_char="825" id="token-7-4" morph="none" pos="word" start_char="823">con</TOKEN>
<TOKEN end_char="828" id="token-7-5" morph="none" pos="word" start_char="827">el</TOKEN>
<TOKEN end_char="834" id="token-7-6" morph="none" pos="word" start_char="830">mayor</TOKEN>
<TOKEN end_char="841" id="token-7-7" morph="none" pos="word" start_char="836">número</TOKEN>
<TOKEN end_char="844" id="token-7-8" morph="none" pos="word" start_char="843">de</TOKEN>
<TOKEN end_char="854" id="token-7-9" morph="none" pos="word" start_char="846">pacientes</TOKEN>
<TOKEN end_char="858" id="token-7-10" morph="none" pos="word" start_char="856">que</TOKEN>
<TOKEN end_char="866" id="token-7-11" morph="none" pos="word" start_char="860">analiza</TOKEN>
<TOKEN end_char="871" id="token-7-12" morph="none" pos="word" start_char="868">este</TOKEN>
<TOKEN end_char="883" id="token-7-13" morph="none" pos="word" start_char="873">tratamiento</TOKEN>
<TOKEN end_char="886" id="token-7-14" morph="none" pos="word" start_char="885">en</TOKEN>
<TOKEN end_char="895" id="token-7-15" morph="none" pos="unknown" start_char="888">COVID-19</TOKEN>
<TOKEN end_char="896" id="token-7-16" morph="none" pos="punct" start_char="896">.</TOKEN>
<TRANSLATED_TEXT>This is the study with the largest number of patients analyzing this treatment in COVID-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1036" id="segment-8" start_char="898">
<ORIGINAL_TEXT>Se administró tratamiento con lopinavir/ritonavir al 63% de los pacientes, por lo general los que se encontraban en condiciones más graves.</ORIGINAL_TEXT>
<TOKEN end_char="899" id="token-8-0" morph="none" pos="word" start_char="898">Se</TOKEN>
<TOKEN end_char="910" id="token-8-1" morph="none" pos="word" start_char="901">administró</TOKEN>
<TOKEN end_char="922" id="token-8-2" morph="none" pos="word" start_char="912">tratamiento</TOKEN>
<TOKEN end_char="926" id="token-8-3" morph="none" pos="word" start_char="924">con</TOKEN>
<TOKEN end_char="946" id="token-8-4" morph="none" pos="unknown" start_char="928">lopinavir/ritonavir</TOKEN>
<TOKEN end_char="949" id="token-8-5" morph="none" pos="word" start_char="948">al</TOKEN>
<TOKEN end_char="952" id="token-8-6" morph="none" pos="word" start_char="951">63</TOKEN>
<TOKEN end_char="953" id="token-8-7" morph="none" pos="punct" start_char="953">%</TOKEN>
<TOKEN end_char="956" id="token-8-8" morph="none" pos="word" start_char="955">de</TOKEN>
<TOKEN end_char="960" id="token-8-9" morph="none" pos="word" start_char="958">los</TOKEN>
<TOKEN end_char="970" id="token-8-10" morph="none" pos="word" start_char="962">pacientes</TOKEN>
<TOKEN end_char="971" id="token-8-11" morph="none" pos="punct" start_char="971">,</TOKEN>
<TOKEN end_char="975" id="token-8-12" morph="none" pos="word" start_char="973">por</TOKEN>
<TOKEN end_char="978" id="token-8-13" morph="none" pos="word" start_char="977">lo</TOKEN>
<TOKEN end_char="986" id="token-8-14" morph="none" pos="word" start_char="980">general</TOKEN>
<TOKEN end_char="990" id="token-8-15" morph="none" pos="word" start_char="988">los</TOKEN>
<TOKEN end_char="994" id="token-8-16" morph="none" pos="word" start_char="992">que</TOKEN>
<TOKEN end_char="997" id="token-8-17" morph="none" pos="word" start_char="996">se</TOKEN>
<TOKEN end_char="1009" id="token-8-18" morph="none" pos="word" start_char="999">encontraban</TOKEN>
<TOKEN end_char="1012" id="token-8-19" morph="none" pos="word" start_char="1011">en</TOKEN>
<TOKEN end_char="1024" id="token-8-20" morph="none" pos="word" start_char="1014">condiciones</TOKEN>
<TOKEN end_char="1028" id="token-8-21" morph="none" pos="word" start_char="1026">más</TOKEN>
<TOKEN end_char="1035" id="token-8-22" morph="none" pos="word" start_char="1030">graves</TOKEN>
<TOKEN end_char="1036" id="token-8-23" morph="none" pos="punct" start_char="1036">.</TOKEN>
<TRANSLATED_TEXT>Treatment with lopinavir / ritonavir was administered to 63% of patients, usually those in more severe conditions.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1293" id="segment-9" start_char="1038">
<ORIGINAL_TEXT>Una de sus principales conclusiones es que su uso no puede asociarse con una reducción de la mortalidad, ni tampoco su temprana utilización (mediana de 5 días) ha mostrado significativos beneficios, por lo que se desaconseja su uso frente a esta patología.</ORIGINAL_TEXT>
<TOKEN end_char="1040" id="token-9-0" morph="none" pos="word" start_char="1038">Una</TOKEN>
<TOKEN end_char="1043" id="token-9-1" morph="none" pos="word" start_char="1042">de</TOKEN>
<TOKEN end_char="1047" id="token-9-2" morph="none" pos="word" start_char="1045">sus</TOKEN>
<TOKEN end_char="1059" id="token-9-3" morph="none" pos="word" start_char="1049">principales</TOKEN>
<TOKEN end_char="1072" id="token-9-4" morph="none" pos="word" start_char="1061">conclusiones</TOKEN>
<TOKEN end_char="1075" id="token-9-5" morph="none" pos="word" start_char="1074">es</TOKEN>
<TOKEN end_char="1079" id="token-9-6" morph="none" pos="word" start_char="1077">que</TOKEN>
<TOKEN end_char="1082" id="token-9-7" morph="none" pos="word" start_char="1081">su</TOKEN>
<TOKEN end_char="1086" id="token-9-8" morph="none" pos="word" start_char="1084">uso</TOKEN>
<TOKEN end_char="1089" id="token-9-9" morph="none" pos="word" start_char="1088">no</TOKEN>
<TOKEN end_char="1095" id="token-9-10" morph="none" pos="word" start_char="1091">puede</TOKEN>
<TOKEN end_char="1105" id="token-9-11" morph="none" pos="word" start_char="1097">asociarse</TOKEN>
<TOKEN end_char="1109" id="token-9-12" morph="none" pos="word" start_char="1107">con</TOKEN>
<TOKEN end_char="1113" id="token-9-13" morph="none" pos="word" start_char="1111">una</TOKEN>
<TOKEN end_char="1123" id="token-9-14" morph="none" pos="word" start_char="1115">reducción</TOKEN>
<TOKEN end_char="1126" id="token-9-15" morph="none" pos="word" start_char="1125">de</TOKEN>
<TOKEN end_char="1129" id="token-9-16" morph="none" pos="word" start_char="1128">la</TOKEN>
<TOKEN end_char="1140" id="token-9-17" morph="none" pos="word" start_char="1131">mortalidad</TOKEN>
<TOKEN end_char="1141" id="token-9-18" morph="none" pos="punct" start_char="1141">,</TOKEN>
<TOKEN end_char="1144" id="token-9-19" morph="none" pos="word" start_char="1143">ni</TOKEN>
<TOKEN end_char="1152" id="token-9-20" morph="none" pos="word" start_char="1146">tampoco</TOKEN>
<TOKEN end_char="1155" id="token-9-21" morph="none" pos="word" start_char="1154">su</TOKEN>
<TOKEN end_char="1164" id="token-9-22" morph="none" pos="word" start_char="1157">temprana</TOKEN>
<TOKEN end_char="1176" id="token-9-23" morph="none" pos="word" start_char="1166">utilización</TOKEN>
<TOKEN end_char="1178" id="token-9-24" morph="none" pos="punct" start_char="1178">(</TOKEN>
<TOKEN end_char="1185" id="token-9-25" morph="none" pos="word" start_char="1179">mediana</TOKEN>
<TOKEN end_char="1188" id="token-9-26" morph="none" pos="word" start_char="1187">de</TOKEN>
<TOKEN end_char="1190" id="token-9-27" morph="none" pos="word" start_char="1190">5</TOKEN>
<TOKEN end_char="1195" id="token-9-28" morph="none" pos="word" start_char="1192">días</TOKEN>
<TOKEN end_char="1196" id="token-9-29" morph="none" pos="punct" start_char="1196">)</TOKEN>
<TOKEN end_char="1199" id="token-9-30" morph="none" pos="word" start_char="1198">ha</TOKEN>
<TOKEN end_char="1208" id="token-9-31" morph="none" pos="word" start_char="1201">mostrado</TOKEN>
<TOKEN end_char="1223" id="token-9-32" morph="none" pos="word" start_char="1210">significativos</TOKEN>
<TOKEN end_char="1234" id="token-9-33" morph="none" pos="word" start_char="1225">beneficios</TOKEN>
<TOKEN end_char="1235" id="token-9-34" morph="none" pos="punct" start_char="1235">,</TOKEN>
<TOKEN end_char="1239" id="token-9-35" morph="none" pos="word" start_char="1237">por</TOKEN>
<TOKEN end_char="1242" id="token-9-36" morph="none" pos="word" start_char="1241">lo</TOKEN>
<TOKEN end_char="1246" id="token-9-37" morph="none" pos="word" start_char="1244">que</TOKEN>
<TOKEN end_char="1249" id="token-9-38" morph="none" pos="word" start_char="1248">se</TOKEN>
<TOKEN end_char="1261" id="token-9-39" morph="none" pos="word" start_char="1251">desaconseja</TOKEN>
<TOKEN end_char="1264" id="token-9-40" morph="none" pos="word" start_char="1263">su</TOKEN>
<TOKEN end_char="1268" id="token-9-41" morph="none" pos="word" start_char="1266">uso</TOKEN>
<TOKEN end_char="1275" id="token-9-42" morph="none" pos="word" start_char="1270">frente</TOKEN>
<TOKEN end_char="1277" id="token-9-43" morph="none" pos="word" start_char="1277">a</TOKEN>
<TOKEN end_char="1282" id="token-9-44" morph="none" pos="word" start_char="1279">esta</TOKEN>
<TOKEN end_char="1292" id="token-9-45" morph="none" pos="word" start_char="1284">patología</TOKEN>
<TOKEN end_char="1293" id="token-9-46" morph="none" pos="punct" start_char="1293">.</TOKEN>
<TRANSLATED_TEXT>One of his main conclusions is that its use cannot be associated with a reduction in mortality, nor has its early use (median 5 days) shown significant benefits, so its use is discouraged in the face of this pathology.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1317" id="segment-10" start_char="1296">
<ORIGINAL_TEXT>Equipo Biblioteca H12O</ORIGINAL_TEXT>
<TOKEN end_char="1301" id="token-10-0" morph="none" pos="word" start_char="1296">Equipo</TOKEN>
<TOKEN end_char="1312" id="token-10-1" morph="none" pos="word" start_char="1303">Biblioteca</TOKEN>
<TOKEN end_char="1317" id="token-10-2" morph="none" pos="word" start_char="1314">H12O</TOKEN>
<TRANSLATED_TEXT>Library H12O</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>